Apalutamide will decrease the extent or outcome of ethinylestradiol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Keep away from or Use Alternate Drug. Coadministration of apalutamide, a strong CYP3A4 inducer, with medication which can be CYP3A4 substrates may end up in reduce publicity to these remedies. This facts would not switch https://heinzm654xlx8.wikidirective.com/user